Search results for: England

Is There Societal Support for an End of Life Premium?

8 May 2017

…policy context in England, focusing on NICE’s appraisals of life-extending end of life treatments and recent changes to the Cancer Drugs Fund. He then presented the findings of a review…

OHE at HTAi 2017: Meet the Team

13 June 2017

…This study compares the availability and access to orphan medicinal products in the UK (England, Scotland and Wales), France, Germany, Italy and Spain. Orphan drugs are authorised in all EU…

Professor Dame Sally Davies: Ten Years of the NIHR: Achievements and Challenges for the Next Decade

15 June 2017

…in sequencing the human genome and translating the results into clinical practice. Dame Sally was appointed Chief Medical Officer for England and Chief Medical Advisor to the UK Government in…

Adaptation to Health States: Sick Yet Better Off?

21 June 2017

…However, controversy remains on the methodological underpinning of how health outcome measurements are obtained. For instance, health technology assessment in England by the National Institute of Health and Care Excellence…

OHE Lunchtime Seminar: NHS Agency Staffing and the Impact of Recent Interventions

6 September 2017

…and the impact of recent interventions. Temporary agency staffing has been a major area of focus for the NHS in England over the last five years. In the context of…

OHE at ISPOR’s 20th Annual European Congress: Presentations

…last 20 years. There are important differences between the 5L value set for England and the UK 3L value set, but, to some extent, these are attributable to the ‘unusual’…

Comparing Preference-based Outcome Measures for Overactive Bladder: EQ-5D-5L vs OAB-5D

31 January 2018

…calculated using the recently published EQ-5D-5L value set for England, making this one of the first published analyses to be carried out using the new value set. In the 2,054…

Valuing Health at the End of Life: A Review of Stated Preference Studies in the Social Sciences Literature

9 April 2018

…in England, where since 2009 NICE has adopted a supplementary policy in its technology appraisal programme that effectively applies a premium for life-extending end of life treatments. Public preferences have…

Invitation to OHE’s Annual Lecture 2018: Is There an Economic Case for Investing in the NHS? Really?

11 July 2018

…is a good use of public finance. The UK government’s decision to increase NHS England’s budget by £20bn in real terms by 2023 is widely regarded as not enough by…